{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T05:35:13Z","timestamp":1782452113457,"version":"3.54.5"},"publisher-location":"New York, NY","reference-count":20,"publisher":"Springer New York","isbn-type":[{"value":"9781493965250","type":"print"},{"value":"9781493965274","type":"electronic"}],"license":[{"start":{"date-parts":[[2016,10,20]],"date-time":"2016-10-20T00:00:00Z","timestamp":1476921600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1007\/978-1-4939-6527-4_26","type":"book-chapter","created":{"date-parts":[[2016,10,19]],"date-time":"2016-10-19T09:26:03Z","timestamp":1476869163000},"page":"355-364","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["How to Distinguish Between the Activity of HDAC1-3 and HDAC6 with Western Blot"],"prefix":"10.1007","author":[{"given":"Mandy","family":"Beyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Kiweler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siavosh","family":"Mahboobi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver H.","family":"Kr\u00e4mer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,20]]},"reference":[{"key":"26_CR1","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.biocel.2008.08.027","volume":"41","author":"S Spange","year":"2009","unstructured":"Spange S, Wagner T, Heinzel T, Kr\u00e4mer OH (2009) Acetylation of non-histone proteins modulates cellular signalling at multiple levels. Int J Biochem Cell Biol 41:185\u2013198","journal-title":"Int J Biochem Cell Biol"},{"key":"26_CR2","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/onc.2009.334","volume":"29","author":"A Villagra","year":"2009","unstructured":"Villagra A, Sotomayor EM, Seto E (2009) Histone deacetylases and the immunological network: implications in cancer and inflammation. Oncogene 29:157\u2013173","journal-title":"Oncogene"},{"key":"26_CR3","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.canlet.2009.02.028","volume":"280","author":"M Buchwald","year":"2009","unstructured":"Buchwald M, Kr\u00e4mer OH, Heinzel T (2009) HDACi\u2014targets beyond chromatin. Cancer Lett 280:160\u2013167","journal-title":"Cancer Lett"},{"key":"26_CR4","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.tips.2009.09.007","volume":"30","author":"OH Kr\u00e4mer","year":"2009","unstructured":"Kr\u00e4mer OH (2009) HDAC2: a critical factor in health and disease. Trends Pharmacol Sci 30:647\u2013655","journal-title":"Trends Pharmacol Sci"},{"key":"26_CR5","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/pros.20022","volume":"59","author":"K Halkidou","year":"2004","unstructured":"Halkidou K, Gaughan L, Cook S, Leung HY, Neal DE, Robson CN (2004) Upregulation and nuclear recruitment of HDAC1 in hormone refractory prostate cancer. Prostate 59:177\u2013189","journal-title":"Prostate"},{"key":"26_CR6","doi-asserted-by":"publisher","first-page":"13548","DOI":"10.1074\/jbc.M510023200","volume":"281","author":"AJ Wilson","year":"2006","unstructured":"Wilson AJ, Byun DS, Popova N, Murray LB, L\u2019Italien K, Sowa Y, Arango D, Velcich A, Augenlicht LH, Mariadason JM (2006) Histone deacetylase 3 (HDAC3) and other class I HDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer. J Biol Chem 281:13548\u201313558","journal-title":"J Biol Chem"},{"key":"26_CR7","doi-asserted-by":"publisher","first-page":"994","DOI":"10.7150\/ijms.8522","volume":"11","author":"SH Lee","year":"2014","unstructured":"Lee SH, Yoo C, Im S, Jung JH, Choi HJ, Yoo J (2014) Expression of histone deacetylases in diffuse large B-cell lymphoma and its clinical significance. Int J Med Sci 11:994\u20131000","journal-title":"Int J Med Sci"},{"key":"26_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s10549-005-6001-1","volume":"94","author":"Z Zhang","year":"2005","unstructured":"Zhang Z, Yamashita H, Toyama T, Sugiura H, Ando Y, Mita K, Hamaguchi M, Hara Y, Kobayashi S, Iwase H (2005) Quantitation of HDAC1 mRNA expression in invasive carcinoma of the breast. Breast Cancer Res Treat 94:11\u201316","journal-title":"Breast Cancer Res Treat"},{"key":"26_CR9","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S1535-6108(04)00114-X","volume":"5","author":"P Zhu","year":"2004","unstructured":"Zhu P, Martin E, Mengwasser J, Schlag P, Janssen KP, G\u00f6ttlicher M (2004) Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis. Cancer Cell 5:455\u2013463","journal-title":"Cancer Cell"},{"key":"26_CR10","doi-asserted-by":"publisher","first-page":"6962","DOI":"10.1158\/1078-0432.CCR-04-0455","volume":"10","author":"Z Zhang","year":"2004","unstructured":"Zhang Z, Yamashita H, Toyama T, Sugiura H, Omoto Y, Ando Y, Mita K, Hamaguchi M, Hayashi S, Iwase H (2004) HDAC6 expression is correlated with better survival in breast cancer. Clin Cancer Res 10:6962\u20136968","journal-title":"Clin Cancer Res"},{"key":"26_CR11","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nrd4360","volume":"13","author":"KJ Falkenberg","year":"2014","unstructured":"Falkenberg KJ, Johnstone RW (2014) Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders. Nat Rev Drug Discov 13:673\u2013691","journal-title":"Nat Rev Drug Discov"},{"key":"26_CR12","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/nrd2133","volume":"5","author":"JE Bolden","year":"2006","unstructured":"Bolden JE, Peart MJ, Johnstone RW (2006) Anticancer activities of histone deacetylase inhibitors. Nat Rev Drug Discov 5:769\u2013784","journal-title":"Nat Rev Drug Discov"},{"key":"26_CR13","doi-asserted-by":"publisher","first-page":"9633","DOI":"10.1073\/pnas.0803749105","volume":"105","author":"RB Parmigiani","year":"2008","unstructured":"Parmigiani RB, Xu WS, Venta-Perez G, Erdjument-Bromage H, Yaneva M, Tempst P, Marks PA (2008) HDAC6 is a specific deacetylase of peroxiredoxins and is involved in redox regulation. Proc Natl Acad Sci U S A 105:9633\u20139638","journal-title":"Proc Natl Acad Sci U S A"},{"key":"26_CR14","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.tips.2014.08.001","volume":"35","author":"OH Kr\u00e4mer","year":"2014","unstructured":"Kr\u00e4mer OH, Mahboobi S, Sellmer A (2014) Drugging the HDAC6-HSP90 interplay in malignant cells. Trends Pharmacol Sci 35:501\u2013509","journal-title":"Trends Pharmacol Sci"},{"key":"26_CR15","doi-asserted-by":"publisher","first-page":"12617","DOI":"10.1073\/pnas.1006774107","volume":"107","author":"JE Bradner","year":"2010","unstructured":"Bradner JE, Mak R, Tanguturi SK, Mazitschek R, Haggarty SJ, Ross K, Chang CY, Bosco J, West N, Morse E, Lin K, Shen JP, Kwiatkowski NP, Gheldof N, Dekker J, DeAngelo DJ, Carr SA, Schreiber SL, Golub TR, Ebert BL (2010) Chemical genetic strategy identifies histone deacetylase 1 (HDAC1) and HDAC2 as therapeutic targets in sickle cell disease. Proc Natl Acad Sci U S A 107:12617\u201312622","journal-title":"Proc Natl Acad Sci U S A"},{"key":"26_CR16","doi-asserted-by":"publisher","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","volume":"20","author":"M G\u00f6ttlicher","year":"2001","unstructured":"G\u00f6ttlicher M, Minucci S, Zhu P, Kr\u00e4mer OH, Schimpf A, Giavara S, Sleeman JP, Lo Coco F, Nervi C, Pelicci PG, Heinzel T (2001) Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J 20:6969\u20136978","journal-title":"EMBO J"},{"key":"26_CR17","doi-asserted-by":"publisher","first-page":"3971","DOI":"10.1200\/JCO.2005.16.600","volume":"23","author":"KN Bhalla","year":"2005","unstructured":"Bhalla KN (2005) Epigenetic and chromatin modifiers as targeted therapy of hematologic malignancies. J Clin Oncol 23:3971\u20133993","journal-title":"J Clin Oncol"},{"key":"26_CR18","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1124\/jpet.103.055541","volume":"307","author":"E Hu","year":"2003","unstructured":"Hu E, Dul E, Sung CM, Chen Z, Kirkpatrick R, Zhang GF, Johanson K, Liu R, Lago A, Hofmann G, Macarron R, de los Frailes M, Perez P, Krawiec J, Winkler J, Jaye M (2003) Identification of novel isoform-selective inhibitors within class I histone deacetylases. J Pharmacol Exp Ther 307:720\u2013728","journal-title":"J Pharmacol Exp Ther"},{"key":"26_CR19","doi-asserted-by":"publisher","first-page":"5781","DOI":"10.1158\/0008-5472.CAN-05-4186","volume":"66","author":"P Maiso","year":"2006","unstructured":"Maiso P, Carvajal-Vergara X, Ocio EM, Lopez-Perez R, Mateo G, Gutierrez N, Atadja P, Pandiella A, San Miguel JF (2006) The histone deacetylase inhibitor LBH589 is a potent antimyeloma agent that overcomes drug resistance. Cancer Res 66:5781\u20135789","journal-title":"Cancer Res"},{"key":"26_CR20","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1042\/BC20080158","volume":"101","author":"A Brandl","year":"2009","unstructured":"Brandl A, Heinzel T, Kr\u00e4mer OH (2009) Histone deacetylases: salesmen and customers in the post-translational modification market. Biol Cell 101:193\u2013205","journal-title":"Biol Cell"}],"container-title":["Methods in Molecular Biology","HDAC\/HAT Function Assessment and Inhibitor Development"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-6527-4_26","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T00:57:28Z","timestamp":1558054648000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-6527-4_26"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,20]]},"ISBN":["9781493965250","9781493965274"],"references-count":20,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-6527-4_26","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,20]]},"assertion":[{"value":"20 October 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}